Origen Therapeutics, Inc.
5885 Hollis Street
Emeryville
California
94608
United States
Tel: 510-597-5100
Website: http://www.origentherapeutics.com/
Email: info@origentherapeutics.com
9 articles about Origen Therapeutics, Inc.
-
Genavia Therapeutics Licenses Technology from Origen Therapeutics, Inc. for Cost-Efficient Production of Human Therapeutics in Chicken Eggs
3/9/2009
-
Symphogen A/S And Origen Therapeutics, Inc. Collaborate to Produce Transgenic Chicken for Generation of Fully Human Antibody Therapeutics
3/6/2009
-
Origen Therapeutics, Inc. Announces Change In Chief Financial Officer And Reports Naked Short Selling To SEC
10/6/2008
-
Origen Therapeutics, Inc. Appoints Phil Leighton as Director of Research and Announces Departure of Robert Etches, VP of Research
6/23/2008
-
Origen Therapeutics, Inc. Receives $2 Million ATP Grant to Advance Technology for Discovery and Production of Human Polyclonal Antibodies from Transgenic Chickens
10/3/2007
-
Origen Therapeutics, Inc. Publishes In Nature A Robust And Versatile Method For Creating Transgenic Chickens
6/8/2006
-
Chickens Genetically Altered To Pass On Inserted Trait
6/8/2006
-
New Chicken Gene-Transfer System Holds Promise For Research And Industry
6/7/2006
-
First Production Of Human Monoclonal Antibodies In Chicken Eggs Published In Nature Biotechnology
8/29/2005